Gonorrhea is a sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. It can infect the genital tract, rectum and throat, sometimes without any noticeable symptoms. Appropriate antibiotics can cure the infection, but delayed diagnosis can allow complications and transmission to partners. Having had gonorrhea before does not provide reliable protection against another infection.
The important questions are where exposure occurred, which tests are needed, whether complications are present and how treatment and partner care will be completed. For someone seeking care in Vietnam, international information provides useful context, while the treating clinician must use current locally applicable guidance and resistance information. An old prescription or an online antibiotic recommendation is not a dependable treatment plan.
How gonorrhea spreads
Transmission occurs mainly during vaginal, anal or oral sex with a person who has the infection. A pregnant person can also pass it to a baby during delivery. Someone who feels well may still carry and transmit the bacteria, so the absence of discharge or pain in a partner does not establish that exposure was safe.
The site of infection depends partly on the type of contact. Oral sex can expose the throat, while anal sex can expose the rectum. More than one site may be infected at the same time. Sharing sex toys without appropriate cleaning or changing their condom covering can also transfer infected secretions. A diagnosis is a reason to arrange care and discuss relevant contacts; it cannot reliably establish when the infection was acquired or justify conclusions about a relationship from symptoms alone.
Genital symptoms and silent infection
Urethral infection may cause burning when urinating and white, yellow or green discharge from the penis. Some people develop testicular discomfort. Cervical infection often produces few or no symptoms, but increased vaginal discharge, urinary discomfort or bleeding between periods can occur. Symptoms may be mistaken for a urinary tract infection or another vaginal condition.
Appearance alone cannot distinguish gonorrhea from chlamydia or other causes of inflammation. A normal-looking genital area does not rule out infection either. Arrange assessment if a partner has been diagnosed, even if you feel completely well. When symptoms are present, their severity does not reliably indicate how long the infection has been there. Testing is more useful than comparing discharge with photographs or waiting for a particular colour to appear.
Throat and rectal infection
Throat infection frequently causes no symptoms and can be missed if testing focuses only on urine or genital samples. A sore throat after sexual contact has many possible causes; neither its presence nor its absence can confirm gonorrhea. Tell the clinician about oral exposure so that an appropriate throat sample can be considered.
Rectal infection may also be silent, or cause discharge, soreness, itching, bleeding or pain during bowel movements. Gonorrhea is one possible cause of sexually acquired proctitis, but chlamydia, herpes and other infections can produce similar problems. Significant rectal pain or bleeding deserves examination rather than repeated treatment for presumed haemorrhoids. Tests should match the exposed body sites, regardless of sexual orientation or gender identity. A negative urine result does not automatically clear the throat or rectum.
Which tests are used?
Nucleic acid amplification tests, often called NAATs, detect genetic material from the organism. Depending on anatomy and the clinical situation, samples may include first-catch urine, a vaginal swab or swabs from other exposed sites. Some services offer self-collected swabs with instructions. Follow the collection directions because the specimen requirements differ between tests.
Culture grows the bacteria and can support antibiotic susceptibility testing. It is particularly important when resistance or treatment failure is suspected. A NAAT result alone generally does not show which antibiotic will work. Routine blood tests do not replace site-specific gonorrhea testing, although blood tests may be offered for HIV or syphilis. If a test was taken very soon after exposure, ask whether repeat testing is needed. Do not delay care for symptoms or a known infected partner while waiting for a theoretical testing window.
Pelvic inflammatory disease and fertility
Infection can spread into the upper reproductive tract and contribute to pelvic inflammatory disease, or PID. Symptoms can include lower abdominal pain, fever, pain during sex or unusual bleeding, but PID can also be relatively subtle. Prompt assessment matters because damage may occur even when symptoms are not dramatic.
Inflammation and scarring can increase the risk of chronic pelvic pain, infertility and ectopic pregnancy. Treating the infection helps prevent further harm but cannot reliably reverse established scarring. PID requires its own clinical assessment and treatment approach; a simple gonorrhea regimen may not cover all organisms involved. Severe pain, vomiting, fainting or possible pregnancy with pelvic pain needs urgent evaluation. These symptoms have other important causes as well, including ectopic pregnancy, so a previous STI diagnosis should not narrow the assessment prematurely.
Testicular pain and other urgent complications
Gonorrhea can cause epididymitis, inflammation of the tube behind the testicle, often with pain and swelling on one side. Other infections can cause the same condition. Sudden severe testicular pain must be assessed urgently because testicular torsion can threaten the testicle and cannot safely be distinguished at home from infection.
Rarely, gonorrhea spreads beyond the initial site into the bloodstream or joints. Fever with a painful swollen joint, tendon pain or a new pustular rash may indicate disseminated infection and requires prompt medical assessment. Eye exposure can cause severe conjunctivitis; marked redness, pain, copious discharge or reduced vision should be treated as urgent. These complications need more than a routine prescription for uncomplicated genital infection, and hospital care or specialist input may be necessary.
Pregnancy and newborn infection
Gonorrhea during pregnancy should be assessed and treated promptly even without symptoms. The clinician needs to know about pregnancy or the possibility of pregnancy because this affects antibiotic choices and any treatment for accompanying infections. Do not assume that a previous prescription remains suitable, or avoid necessary treatment because all antibiotics are thought to be unsafe.
A baby exposed during birth can develop serious eye infection and, less commonly, infection elsewhere. Newborn eye discharge, swollen eyelids or illness needs urgent paediatric assessment. Eye drops alone are not adequate treatment for established gonococcal disease in a newborn. Maternal testing, appropriate treatment and partner management help prevent exposure. Follow the maternity team's screening and follow-up plan; a negative earlier result does not prevent a new infection later in pregnancy.
Treatment must reflect current evidence
Ceftriaxone injection remains central to many established gonorrhea treatment guidelines. The appropriate regimen depends on infection site, complications, allergy history, pregnancy and other factors. Treatment for chlamydia may also be needed when that infection has not been excluded. Additional antibiotics are not automatically beneficial simply because more medicines appear stronger.
Treatment options are evolving. In December 2025, the US FDA approved two oral therapies for specified patients with uncomplicated urogenital gonorrhea. Those approvals do not establish suitability for throat infection, pregnancy or complicated disease, and do not establish availability or approval in Vietnam. A clinician must check the relevant product indication and local guidance. Do not copy an overseas regimen, self-inject antibiotics or substitute a pharmacy product because its name sounds similar. Report significant previous antibiotic reactions before treatment so that alternatives can be assessed safely.
Why antibiotic resistance matters
Resistance means the bacteria can survive medicines that would ordinarily kill them or stop their growth. It is the organism becoming resistant, not the patient's body becoming accustomed to treatment. Gonorrhea has developed resistance to multiple antibiotic classes, making surveillance and careful prescribing especially important.
Leftover tablets, incomplete courses and unverified combinations can fail to eradicate infection. Symptoms may temporarily improve without proving cure. Do not share treatment with a partner: each person needs an appropriate assessment, and the required treatment may differ. Tell the clinician what antibiotics were already taken, including doses and timing, because this can affect interpretation of tests. When failure is suspected, obtaining suitable samples before further treatment can help identify resistance. A persistent problem deserves reassessment, not an escalating sequence of self-selected medicines.
Follow-up: cure testing and later retesting
A test of cure checks whether the original infection has cleared. The need and timing depend on the infected site, regimen and local guidance. For example, CDC guidance recommends a throat-infection test of cure seven to fourteen days after treatment, while routine cure testing is not required for every uncomplicated genital or rectal infection treated with a recommended regimen.
Testing too early can complicate interpretation because a NAAT may detect remaining genetic material. Follow the requested timing and ask how a positive result will be confirmed. Separately, retesting around three months after treatment is recommended in CDC guidance to identify reinfection, even when partners were treated. This later test serves a different purpose. Persistent or returning symptoms need earlier review; do not wait three months. Reinfection is common, but genuine treatment failure and other causes of symptoms must also be considered.
Partner treatment and returning to sex
Recent sexual partners may need assessment and treatment even when they have no symptoms. The clinician can explain which contacts should be informed and help with a safe, confidential notification approach. The relevant look-back period depends on guidance and the history; it should not be guessed only from the day symptoms appeared.
Avoid vaginal, anal and oral sex during the treatment period. CDC advice includes waiting seven days after treatment and ensuring that partners have completed treatment and symptoms have resolved; follow the specific instructions for your regimen and any accompanying infection. If partners receive treatment on different days, their timing matters too. A condom does not replace the advised abstinence period. Resuming sex with an untreated partner can lead to reinfection immediately after otherwise successful treatment. Agree on follow-up rather than assuming a partner's symptoms disappearing proves clearance.
Other infections and a recent exposure
A gonorrhea diagnosis is an opportunity to test for other relevant infections, particularly chlamydia, syphilis and HIV. These infections require different tests and treatments. A course that treats gonorrhea should not be assumed to treat all STIs, and a negative result for one infection says nothing definite about another.
If a recent exposure may also carry HIV risk, seek urgent advice about post-exposure prophylaxis, or PEP. It must be started within seventy-two hours, and earlier is better; do not wait for the gonorrhea result. PEP is a specific HIV prevention treatment, not a gonorrhea cure. People with ongoing HIV exposure risk can discuss pre-exposure prophylaxis, or PrEP, which likewise does not prevent gonorrhea. After sexual assault, urgent trauma-informed care can address injuries, infection prevention and other time-sensitive needs without requiring the person to manage these decisions alone.
Reducing future transmission
Use a new condom correctly throughout each act of vaginal, anal or oral sex, and appropriate barriers for other oral contact. Water-based or suitable silicone-based lubricant can reduce friction; oil-based products can damage latex. Do not use two external condoms together or reuse a condom. Change the condom between partners or body sites and follow cleaning instructions for sex toys.
Barrier protection reduces risk but does not eliminate it. Regular testing should reflect exposure patterns and clinical advice, because symptoms are an unreliable screening tool. A mutually monogamous relationship reduces exposure when both partners have been tested and are uninfected. Washing, urinating or using antiseptic products after sex does not replace prevention or testing. The practical route to recovery is accurate diagnosis, appropriate antibiotics, partner care and the right follow-up, without stigma or assumptions about who can acquire an STI.
Frequently Asked Questions
Can I use this article to diagnose or treat myself?
No. It provides general information and practical planning points. A clinician or pharmacist should assess individual symptoms, diagnoses, medicines and treatment decisions.
What information should I verify before acting?
Verify details that can change, such as appointment schedules, fees, medicine stock, service availability and local instructions, using the current official source.
What should I bring to a medical appointment?
Bring identification when required, a medication and allergy list, relevant previous records and a short timeline of symptoms. For specialist care, include prior imaging or test reports when available.
When should I seek urgent medical help?
Seek urgent care for severe or rapidly worsening symptoms, breathing difficulty, fainting, major bleeding, new neurological symptoms or another situation that feels immediately dangerous.
Should a partner be tested after a gonorrhea diagnosis?
Yes. Recent sexual partners need medical assessment, testing and treatment guidance to reduce reinfection and further transmission.
Sources
Writer
Tan Nguyen
Medical writer for Vietnam Clinic. MD, Vietnam National University Ho Chi Minh City.
